다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Inc (VRTX) 뉴스

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	01:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	00:50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	00:41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/15	23:30	Business Wire	Jennifer Schneider Elected to Vertex Board of Directors	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/10	21:01	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/08	21:54	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/08	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	20:46	IH Market News	Disney Slashes Streaming Losses, UBS shoots up 9% as profit triples expectations, and More in Earnings	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	05:01	Business Wire	Vertex Reports First Quarter 2024 Financial Results	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/06	21:09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/27	00:43	Business Wire	Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13:45	PR Newswire (Canada)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13:45	PR Newswire (US)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13:45	PR Newswire (US)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/18	21:00	Business Wire	Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	20:24	IH Market News	Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More News	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	05:01	Business Wire	Vertex Enters Into Agreement to Acquire Alpine Immune Sciences	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	05:01	Business Wire	Vertex Enters Into Agreement to Acquire Alpine Immune Sciences	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/10	05:05	Business Wire	Vertex to Announce First Quarter 2024 Financial Results on May 6	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/02	00:00	PR Newswire (Canada)	Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/02	00:00	PR Newswire (Canada)	Vertex annonce que la présentation de drogue nouvelle d'Exagamglogène Autotemcel (exa-cel) a été acceptée pour évaluation prioritaire par Santé Canada pour le traitement de l'anémie falciforme et de la bêta-thalassémie dépendante des transfusion	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/01	21:00	Business Wire	Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/03/21	21:00	Business Wire	Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/02/28	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/02/28	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/02/28	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/02/28	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/02/28	06:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

Verizon Communications

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관